Showing results (5161-5170 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|July 6, 2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemiaYilin Chen, Na Xu, Yunfan Yang, et al.Cancer Medicine|June 30, 2023
Development and validation of a nomogram to predict the recurrence of eyelid sebaceous gland carcinomaZihan Nie, Jialu Geng, Xiaolin Xu, et al.Cancer Medicine|June 30, 2023
Epidemiology, treatments, and related biomarkers of locally advanced or metastatic urothelial carcinoma in Chinese population: A scoping reviewWang He, Changhao Chen, Tianxin Lin, et al.Cancer Medicine|June 30, 2023
Mutational pattern off homologous recombination repair (HRR)-related genes in upper tract urothelial carcinomaKaiwei Yang, Wei Yu, Huanhuan Liu, et al.Cancer Medicine|June 30, 2023
Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2-low and HER2-zero breast cancer among Chinese femalesLu Zheng, Yunmeng Zhang, Zhipeng Wang, et al.Cancer Medicine|July 13, 2023
Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in GeorgiaSofia Awan, Geetanjali Saini, Keerthi Gogineni, et al.Cancer Medicine|July 12, 2023
ZDHHC11B is decreased in lung adenocarcinoma and inhibits tumorigenesis via regulating epithelial-mesenchymal transitionHuanyu Dai, Ruiyue Wu, Jiatong Zhang, et al.Cancer Medicine|July 27, 2023
Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institutionSandra Fontanals, Anna Esteve, Andrea González, et al.Cancer Medicine|July 27, 2023
Circulating hsa_circ_0072309, acting via the miR-100/ACKR3 pathway, maybe a potential biomarker for the diagnosis, prognosis, and treatment of brain metastasis from non-small-cell lung cancerXiao-Qiang Zhang, Qian Song, Lin-Xiang ZengCancer Medicine|July 26, 2023
The prognosis of clinical stage IIIa non-small cell lung cancer in TaiwanYa-Fu Cheng, Jing-Yang Huang, Ching-Hsiung Lin, et al.Pageof 935